mTORC1 signaling and IL-17 expression: Defining pathways and possible therapeutic targets. (Q38630578)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

mTORC1 signaling and IL-17 expression: Defining pathways and possible therapeutic targets (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

8

Fuller W Bazer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Wenkai Ren

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jie Yin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jielin Duan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Bie Tan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Guan Yang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Guoyao Wu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Yuanyi Peng

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Yulong Yin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

22 December 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

291-299

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26558536%20AND%20SRC:MED&resulttype=core&format=json

Growing knowledge of the mTOR signaling network

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

mTOR signaling in growth control and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

mTOR in aging, metabolism, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Identification of a conserved motif required for mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Identification of Protor as a novel Rictor-binding component of mTOR complex-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

mTOR complex 2 signaling and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

mTORC2 Deficiency in Myeloid Dendritic Cells Enhances Their Allogeneic Th1 and Th17 Stimulatory Ability after TLR4 Ligation In Vitro and In Vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Role of PI3K/Akt and mTOR complexes in Th17 cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

TSC1 regulates the balance between effector and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

CD5 enhances Th17-cell differentiation by regulating IFN-γ response and RORγt localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

The biological functions of T helper 17 cell effector cytokines in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Identity crisis of Th17 cells: many forms, many functions, many questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Stat3 and Stat4 direct development of IL-17-secreting Th cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

STAT3 regulates cytokine-mediated generation of inflammatory helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

The TSC-mTOR signaling pathway regulates the innate inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Intersection of mTOR and STAT signaling in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

SOCS proteins, cytokine signalling and immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Suppression of cytokine signaling: the SOCS perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Interleukin-6 upregulates Th17 response via mTOR/STAT3 pathway in acute-on-chronic hepatitis B liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Rheb promotes cell growth as a component of the insulin/TOR signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORγ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Interdependence of hypoxic and innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Regulation of the p300 HAT domain via a novel activation loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Activation of a metabolic gene regulatory network downstream of mTOR complex 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

mTOR: from growth signal integration to cancer, diabetes and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Molecular mechanisms of mTOR-mediated translational control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Identification and characterization of a mitogen-activated S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Glutamatergic regulation of the p70S6 kinase in primary mouse neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

S6K1 plays a critical role in early adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Multilineage transcriptional priming and determination of alternate hematopoietic cell fates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Gfi1 negatively regulates T(h)17 differentiation by inhibiting RORgammat activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Down-regulation of Gfi-1 expression by TGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Cloning and characterization of a nuclear S6 kinase, S6 kinase-related kinase (SRK); a novel nuclear target of Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Importins and beyond: non-conventional nuclear transport mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Key mediators of intracellular amino acids signaling to mTORC1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Dietary arginine supplementation of mice alters the microbial population and activates intestinal innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Dietary L-glutamine supplementation modulates microbial community and activates innate immunity in the mouse intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Serum amino acids profile and the beneficial effects of L-arginine or L-glutamine supplementation in dextran sulfate sodium colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Innate IL-17-producing cells: the sentinels of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Diversity of IL-17-producing T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

7 January 2021

Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

7 January 2021

The AP-1 transcription factor Batf controls T(H)17 differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

7 January 2021

Early growth response gene-2 controls IL-17 expression and Th17 differentiation by negatively regulating Batf

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545886

7 January 2021